Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Cases where the Fasting Blood sugar greater than 135mg/dl Patients with type 2 diabetes of both sexes who are between the ages of 30 and 70 willbe chosen.
Exclusion criteria
Exclusion criteria: Patients with severe infectious illnesses, retinopathy, neuropathy, nephropathy, and other complications of type 2 diabetes mellitus. Patients whose FBS is greater than 250 mg/dl Patients with extremely weakened immune systems or other severe illnesses, such as carcinomas. Chronic smokers and chronic alcoholics. Patients receiving insulin therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. CELL LINE STUDY Anti-diabetic activity of Cephalandra indica via inhibition of Glucose- 6 phosphatase in hep G2 cells through Cell line study. 2.CLINICAL STUDY Reduction in the fasting plasma glucose concentration Timepoint: 1. CELL LINE STUDY DURATION:4 weeks 2.CLINICAL STUDY DURATION:12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of cephalandra indica and homoeopathic constitutional medicinesTimepoint: 1 year | — |
Countries
India
Contacts
GOVT HOMOEOPATHIC MEDICAL COLLEGE KOZHIKODE